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ABSRACT
Background: Clinical insight is reliably associated with cognitive dysfunction in schizophrenia patients,  with episodic mem-
ory as one of the most impaired forms of memory in this illness.
Objectives: This study aimed to examine clinical insight and its relationship with verbal learning among schizophrenia out-
patient in Kelantan, Malaysia.
Methods: A total of 108 (mean age 33.7 years) stable schizophrenia outpatients were recruited. Clinical insight, psychopa-
thology, and verbal learning were assessed using the Insight and Treatment Attitudes Questionnaire (ITAQ), Brief Psychiatric 
Rating Scale (BPRS), Auditory Verbal Learning Test (AVLT), respectively.
Results: In multiple linear regression final model, verbal delayed memory, duration of illness and primary educational status 
emerged as factors independently associated with clinical insight with 19.4% of the variation explained. No significant associa-
tion was noted between clinical insight with other socio-demographic factors and schizophrenia psychopathology.
Conclusions: Clinical insight was independently associated with verbal delayed memory suggesting the important role of 
verbal memory, particularly delayed recall, in clinical insight. The association with duration of illness was explained by the 
study sample's relatively young age.
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INTRODUCTION
Poor clinical insight has profound prognostic and therapeutic conse-
quences, and has been associated with low adherence to medication1,2), 
greater frequency of hospitalizations and relapse3), poor social and voca-
tional functioning in schizophrenia patients4). Originally a dichotomous 
construct, it has evolved to multidimensional5) with independent but 
overlapping domains such as unawareness of mental disorder, its symp-
toms, implications, and need for treatment5,6). Recent neuroimaging liter-
ature points to common as well as exclusive brain regions associated 
with insight dimensions7).
Cognitive dysfunction8,9), namely executive dysfunction, lower pre-
morbid intelligence, memory, and to a lesser extent, impaired attention10) 
is reliably associated with clinical insight. Memory impairments have 
been established as strong predictors of poor clinical and functional out-
come in schizophrenia11), with episodic memory as one of the most 
impaired forms of memory in this illness12). The inability to self-initiate 
effective memory strategies in the absence of direct prompts correlated 
with a failure to activate the left dorsolateral prefrontal cortex13) rep-
resents a critical factor leading to deficient episodic memory in schizo-
phrenia14).
Nevertheless, patients are usually given psychoeducation to 
improve their clinical insight. The ability to remember health-related 
advice is dependent on patient's ability to listen, comprehend and retain 
information, collectively known as "verbal learning", Thus, this study 
aimed to examine clinical insight and its relationships with verbal learn-
ing among schizophrenia outpatient. The finding would add to the exist-
ing literature about the complex relationship between clinical insight 
and cognition, in particular memory. Since more than half of schizo-
phrenia patients had poor medication adherence15), the finding would be 
crucial in formulating effective strategies to address this issue.
METHODS
Participants and procedure
This research was approved by the HREC of Universiti Sains 
Malaysia and MREC of Health Ministry of Malaysia. The cross-section-
al study was conducted over a period of 9 months in 2014 at Hospital 
Universiti Sains Malaysia (USM) and Hospital Raja Perempuan Zainab 
II (HRPZ-II) which are located in Kota Bharu, northeast of peninsular 
Malaysia.
The objectives and conduct of the study were briefly explained to 
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the participants before obtaining the informed consent. The subject was 
then asked to fill in the self-rated questionnaire of BCIS. After this was 
completed, the information on socio-demographic and clinical data was 
obtained from both interview and clinical records. These were entered 
into the socio-demographic and clinical data form by the researcher. 
Following this, the verbal learning test was then administered using the 
Malay AVLT. Finally, the data collection was completed by using the 
BPRS to assess severity of psychopathology and the ITAQ to assess 
clinical insight during the interview.
Eligible schizophrenia patients attending the regular outpatient clin-
ics were recruited for the study according to the following criteria: age 
(18-65 years), having diagnosis of schizophrenia as per Diagnostic and 
Statistical Manual of Mental Disorders, 4th edition (DSM-IV-TR). 
Exclusion criteria included dementia, prior tramatic brain injury, relapse 
in the preceding 6 months, alcohol or drug dependence, debilitating 
medical or neurological illness, mental retardation or other major axis I 
disorder, and poor command of Malay language.
Measurements
Socio-demographic and clinical data of subjects were obtained 
through interview or from the medical records. Symptoms of schizo-
phrenia were assessed using the Brief Psychiatric Rating Scale (BPRS) 
with scores ranging from 18 to 126. Higher scores indicate more severe 
symptoms16). The scale has high inter-rater reliability (0.62 to 0.87) as 
well as discriminant and concurrent validity17).
Insight was assessed using the Insight and Treatment Attitudes 
Questionnaire (ITAQ) with scores ranging from 0 to 22, with higher 
scores indicating good clinical insight. This well-validated, structured 
interview18), includes 11 questions assessing recognition of mental disor-
der and attitudes towards the need for medication, hospitalization, and 
follow-up care.
The patient's verbal learning and memory was assessed using the 
Malay version of the auditory verbal learning test (AVLT)19). It has a 
good factor validity (factor analysis of 0.66-0.98), test-retest reliability 
(0.24 to 0.84) and is sensitive in discriminating between normal and 
schizophrenia subjects.. Five acquisition trials, using List A, were given 
to each participant giving a total learning score (A1 + A2 + A3 + A4 + 
A5). Then, the participants were required to remember the items in List 
B (B1, interference trial). Following that List A must be repeated (A6, 
post interference, immediate recall memory). A gap of 20 minutes was 
given after A6 whereby at the end of this 20-minute gap, the participant 
was asked to recall List A again (A7, delayed memory recall). The final 
stage of the test involved recognising and identifying 15 List A words 
that were read out from a different list consisting of 30 words (List C) 
Table 1. Socio-demographic and clinical characteristics
Variables  n (%)
Sex
Male 63 (58.3)
Female 45 (41.7)
Race
Malay 105 (97.2)
Chinese 1 (0.9)
Indian -
Others  2 (1.9)
Marital Status
Never married 74 (68.5)
Married 21 (19.4)
Divorced/separated 13 (12.0)
Employment Status
Unemployed 59 (54.6)
Employed  49 (45.4)
Educational Status
Primary 4 (3.7)
Secondary 73 (67.6)
Tertiary  31 (28.7)
Treatment Received
Atypical antipsychotics 67 (62.0)
Typical antipsychotics 24 (22.2)
Both atypical and typical 17 (15.7)
Benzhexol Use
Yes  14 (13.0)
No  94 (87.0)
 Mean(SD)
Age (yrs.) 33.67(10.11)
Duration of Illness (yrs.) 10.96 (7.71)
BPRS 23 (5)*
Verbal Learning 
Total learning 34.19 (10.61)
Delayed recall 7.0 (4)*
Recognition 14.0 (3)*
Insight data
ITAQ 13.52 (4.16)
*Median (IQR) skewed distribution
Table 2. Associated factors of clinical insight by simple lin-
ear regression
Variables ba (95%CI) tb stat p-value
Age 0.09(0.02,0.17) 2.400 0.018*
Gender 0.60(-1.02,2.21) 0.734 0.465
Race   
Malay -0.84(-5.69,4.01) -0.343 0.732
Chinese 6.54(-1.69,14.77) 1.576 0.118*
(Others)   
Marital Status   
Never married -0.15(-1.86,1.57) -0.167 0.868
Married -0.70(2.71,1.31) -0.693 0.490
(Divorced/Separated)   
Employment 1.33(-0.25,2.91) 1.668 0.098*
Educational Status   
Primary 3.88(-0.28,8.03) 1.849 0.067*
Secondary -1.26(-2.95,0.42) -1.484 0.141*
(Tertiary)   
Antipsychotics   
Atypical -1.68(-3.29,-0.07) -2.069 0.041*
Typical 1.80(-0.09,3.68) 1.890 0.062*
(Both)   
Benzhexol Use 1.42(-0.94,3.77) 1.191 0.236*
Duration of illness 0.15(0.05,0.25) 3.059 0.003*
BPRS -0.32(-0.55,-0.08) -2.665 0.009*
Verbal Learning   
Total learning 0.09(0.01,0.16) 2.348 0.021*
Delayed recall 0.41(0.14,0.69) 2.975 0.004*
Recognition 0.28(-0.07,0.64) 1.582 0.117*
acrude regression coefficient; bt statistic;  *p < 0.25, included in the MLR
Table 3. Associated factors of clinical insight by multiple linear 
regression
Variables ba (95%CI) tb stat p-value
Educational Status
Primary 4.73(0.84,8.62) 2.409 0.018
Duration of illness 0.17(0.07,0.26) 3.426 < 0.001
Verbal Learning
Delayed recall 0.37(0.11,0.63) 2.797 0.006
aadjusted regression coefficient; bt statistic; R2 = 0.194. 
No interaction and multicollinearity were found; 
Forward multiple linear regression applied. Model assumptions were met.
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which were semantically or phonetically related. In order to standardize 
the auditory input of List A, B and C, the researcher used a recorded 
audio as used in a previous study20).
Statistical analysis
Statistical Package for Social Sciences (SPSS) version 21 was used 
in the analyses. Mean (SD) was used for normally distributed continu-
ous variables while median (IQR) was used to describe continuous vari-
ables of skewed distribution. Simple and multiple linear regression 
(MLR) analysis methods were employed to identify associated factors 
of clinical insight.
RESULTS
As shown in table 1, a total of 108 patients completed the question-
naires and analysed in this study. The mean age was 33.7 years old. 
Males and females comprised 58.3% (63) and 41.7% (45) of sample, 
respectively. The majority were Malays at 105 (97.2%). Most of them 
were never married (n = 74; 68.5%), unemployed (n = 59; 54.6%), sec-
ondary school educational status (n = 73; 67.6%), receiving atypical 
antipsychotics (n = 67; 62%) and not on benzhexol (n = 94; 87%). The 
mean duration of illness was 10.96 years (SD = 7.71). The BPRS medi-
an score of 23 (IQR = 5) reflected patient's relatively stable mental 
health, which was expected of schizophrenia outpatient. The verbal 
learning scores for total learning (mean = 34.19; SD = 4), delayed recall 
(median = 7; IQR = 4) and recognition (median = 14; IQR = 3) was con-
sistent with working memor deficits, which is comparable to a previous 
study in similar setting21).
The ITAQ mean scores was 13.52 with SD = 4.16. Table 2 rep-
resents the results obtained for clinical insight (ITAQ). The six variables 
significantly associated with clinical insight (p < 0.05) were age, atypi-
cal antipsychotic use, duration of illness, BPRS, total learning and 
delayed recall. On the basis of p < 0.25 with biological importance, a 
further seven variables including Chinese race (p = 0.018), employment 
status (p = 0.098), primary (p = 0.067) and secondary (p = 0.141) educa-
tional status, typical antipsychotic use (p = 0.062), benzhexol use (p = 
0.236) and recognition scores (p = 0.117) were chosen to be included in 
the MLR for analysis. 
From the various methods of MLR, the forward method produced 
the best final equation with three significant variables. Final equation 
for ITAQ = 8.97 + 0.17*(Duration of illness) + 0.37*(Delayed recall) + 
4.73*(Primary educational status).This equation showed that there is a 
significant linear positive relationship between ITAQ score and duration 
of illness, delayed recall and those with primary educational status. 
Therefore, in this model: (1) one year duration of illness corre-
sponds to 0.17 scores higher in ITAQ; (2) one unit of delayed recall cor-
responds 0.37 unit scores higher in ITAQ; and (3) Those with primary 
educational status have 4.73 unit scores higher in ITAQ. According to 
the MLR model, 19.4% of the variation in the ITAQ score was 
explained by duration of illness, delayed recall and primary educational 
status (R2 = 0.194).
DISCUSSION
In a previous study among offenders with schizophrenia, there was 
no significant association observed between clinical insight and general 
cognition measured by mini-mental state examination22). Nevertheless, 
verbal memory represents one of the most affected cognitive domains in 
schizophrenia. In this study, clinical insight was found to be inde-
pendently associated with verbal delayed recall. During encoding, dor-
solateral prefrontal cortex (DLPFC) activation was predictive of subse-
quent semantic clustering. Whereas, subregions of ventrolateral prefron-
tal cortex (VLPFC) were predictive of subsequent recall23). A recent neu-
roimaging study had found that patients with greater verbal memory 
impairments demonstrated significant cortical thinning in the left frontal 
lobe and the parahippocampal gyri24). These regions are known to be 
important in verbal memory performance. However, this study failed to 
find significant association with total learning or acquisition of informa-
tion. 
This study also found non-significant association between recogni-
tion memory and clinical insight. Probably this is related to schizophre-
nia patients intact ability to use semantic strategies to enhance their rec-
ognition memory performances, as compensatory mechanism to severe 
episodic retrieval impairment25). In a similar study26), cognitive insight 
was not associated with verbal memory suggesting the ability to retain 
information to be more relevant to clinical rather than cognitive insight. 
In this study, clinical insight was independently associated with 
duration of illness. This should be interpreted with caution as the rela-
tionship between clinical insight and duration of illness is not necessari-
ly linear. Review of available literature suggests that the course of 
insight impairment follows a U-shaped curve, where insight impairment 
is severe during the first episode of psychosis, modestly improves over 
midlife, and declines again in late life27). In another study, insight 
impairment was more severe in later life (≥ 60 years) than in earlier 
years and the relationships between impaired insight and cognition, par-
ticularly working memory, was stronger in later life than in earlier life28). 
As the mean age in this sample was 33.7 years, it was not surprising to 
note better insight with increasing duration of illness. 
Lastly, clinical insight was independently associated with primary 
educational status which is in contrast to literature where insight is asso-
ciated with number of years in education29). Good premorbid functioning 
including number of years in education and premorbid intelligence rep-
resent better cognition. 
CONCLUSIONS
Clinical insight was independently associated with verbal delayed 
memory suggesting the important role of verbal memory, particularly 
delayed recall, in clinical insight. The association with duration of ill-
ness was explained by the the study sample's relatively young age. 
Lastly, the association with primary educational status was in contrast 
with the notion that number of years in education represents better cog-
nition and predicts better insight.
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